Table 7. Four-year survival probability (% ±SE) in HIPEC and control groups.
| Survival | Control group | HIPEC group | Plog-rank |
|---|---|---|---|
| Overall survival | 34.6±6.6 | 47.1±6.1 | 0.2 |
| Cancer-specific survival | 36.7±6.9 | 51.8±6.3 | 0.09 |
| Progression-free survival | 19.6±5.6 | 47.1±6.3 | <0.001 |
| Dissemination-free survival | 22.7±6.0 | 51.9±6.3 | <0.001 |
| Metastases-free survival | 31.1±6.5 | 42.6±6.0 | 0.2 |
HIPEC, hyperthermic intraperitoneal chemotherapy; SE, standard error.